2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Genitourinary
10
Breast
10
Thoracic
8
Gastrointestinal
8
CNS
7
Head & Neck
6
Sarcoma
4
Lymphoid
2
Gynecologic
2
Tumor-Agnostic
1
Endocrine
1
Dermatologic
1
Conditions
Sarcoma
2
Neoplasms
2
Chordoma
2
Carcinoma, Adenoid Cystic
1
Interventions
Radiotherapy
220
Doxorubicin
210
Cyclophosphamide
210
Temozolomide
182
Ifosfamide
121
Filgrastim
111
Imatinib Mesylate
104
Etoposide
101
Vincristine
92
Gemcitabine
89
Bevacizumab
83
Magnetic Resonance Spectroscopy
80
Irinotecan
79
pembrolizumab
75
Radiation
69
Carboplatin
65
Methotrexate
62
pazopanib
61
Nivolumab
58
Cisplatin
58
fludarabine phosphate
57
Peripheral Blood Stem Cell Transplantation
57
Surgical Procedures, Operative
56
Specimen Handling
56
Trabectedin
52
Docetaxel
50
Biopsy
50
Busulfan
49
Melphalan
46
Paclitaxel
44
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Protons
×
Sarcoma
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled
NCT01811394
2023-12-06
ISAC
Heidelberg University
Phase 2
Unknown
100 enrolled
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled
NCT01182779
2010-08-17
HIT-1
Heidelberg University
Phase 3
Unknown
319 enrolled